4.4 Article

Detection of BPDE-DNA adducts in human umbilical cord blood by LC-MS/MS analysis

Journal

JOURNAL OF FOOD AND DRUG ANALYSIS
Volume 27, Issue 2, Pages 518-525

Publisher

DIGITAL COMMONS BEPRESS
DOI: 10.1016/j.jfda.2019.03.001

Keywords

BPDE-dG; Human biomonitoring; LC-MS/MS; Molecular epidemiology

Funding

  1. National Science and Technology Infrastructure Program, China [2013BAI12B03]

Ask authors/readers for more resources

Benzo [a]pyrene (BaP) is a model compound for the study of polycyclic aromatic hydrocarbon (PAH) carcinogenesis. Upon metabolism, BaP is metabolized to the ultimate metabolite, BaP trans-7,8-diol-anti-9,10-epoxide (BPDE), that reacts with cellular DNA to form BPDE-dG adducts responsible for BaP-induced mutagenicity, carcinogenicity, and teratogenicity. In this study, we employed our developed LC-MS/MS method to detect and quantity BPDE-dG adducts present in 42 normal human umbilical cord blood samples and 42 birth defect cases. We determined that there is no significant difference in the level of BPDE-dG formation between the normal and birth defect groups. This represents the first time to use an LC-MS/MS method to quantify BPDE-dG in human umbilical blood samples. The results indicated that under experimental conditions, BPDE-dG adducts were detected in all the human umbilical cord blood samples from the normal and birth defect groups. Copyright (C) 2019, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available